1. Home
  2. UHT vs SVRA Comparison

UHT vs SVRA Comparison

Compare UHT & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UHT
  • SVRA
  • Stock Information
  • Founded
  • UHT 1986
  • SVRA 2007
  • Country
  • UHT United States
  • SVRA United States
  • Employees
  • UHT N/A
  • SVRA N/A
  • Industry
  • UHT Real Estate Investment Trusts
  • SVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • UHT Real Estate
  • SVRA Health Care
  • Exchange
  • UHT Nasdaq
  • SVRA Nasdaq
  • Market Cap
  • UHT 540.7M
  • SVRA 505.8M
  • IPO Year
  • UHT N/A
  • SVRA N/A
  • Fundamental
  • Price
  • UHT $38.64
  • SVRA $2.99
  • Analyst Decision
  • UHT
  • SVRA Buy
  • Analyst Count
  • UHT 0
  • SVRA 6
  • Target Price
  • UHT N/A
  • SVRA $8.83
  • AVG Volume (30 Days)
  • UHT 46.3K
  • SVRA 728.2K
  • Earning Date
  • UHT 04-28-2025
  • SVRA 05-23-2025
  • Dividend Yield
  • UHT 7.60%
  • SVRA N/A
  • EPS Growth
  • UHT 15.38
  • SVRA N/A
  • EPS
  • UHT 1.35
  • SVRA N/A
  • Revenue
  • UHT $99,725,000.00
  • SVRA N/A
  • Revenue This Year
  • UHT N/A
  • SVRA N/A
  • Revenue Next Year
  • UHT N/A
  • SVRA N/A
  • P/E Ratio
  • UHT $28.72
  • SVRA N/A
  • Revenue Growth
  • UHT 1.03
  • SVRA N/A
  • 52 Week Low
  • UHT $34.56
  • SVRA $2.26
  • 52 Week High
  • UHT $47.30
  • SVRA $5.31
  • Technical
  • Relative Strength Index (RSI)
  • UHT 47.71
  • SVRA 48.32
  • Support Level
  • UHT $38.60
  • SVRA $2.81
  • Resistance Level
  • UHT $39.57
  • SVRA $3.33
  • Average True Range (ATR)
  • UHT 0.75
  • SVRA 0.23
  • MACD
  • UHT 0.08
  • SVRA -0.04
  • Stochastic Oscillator
  • UHT 55.07
  • SVRA 27.92

About UHT Universal Health Realty Income Trust

Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Share on Social Networks: